FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

444648007: Tocilizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2010. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2870396019 Tocilizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2870894010 Tocilizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tocilizumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Tocilizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tocilizumab 20mg/mL solution for intravenous infusion Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
Product containing tocilizumab Has active ingredient True Tocilizumab Inferred relationship Existential restriction modifier 1
Tocilizumab therapy Direct substance True Tocilizumab Inferred relationship Existential restriction modifier 2
Product containing tocilizumab in parenteral dose form (medicinal product form) Has active ingredient True Tocilizumab Inferred relationship Existential restriction modifier 1
Tocilizumab 20mg/mL conventional release solution for injection Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab Has active ingredient True Tocilizumab Inferred relationship Existential restriction modifier 1
Product containing only tocilizumab in parenteral dose form (medicinal product form) Has active ingredient True Tocilizumab Inferred relationship Existential restriction modifier 1
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Tocilizumab Inferred relationship Existential restriction modifier 1
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Tocilizumab Inferred relationship Existential restriction modifier 1
Product containing precisely tocilizumab 180 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Tocilizumab Inferred relationship Existential restriction modifier 1
Product containing precisely tocilizumab 180 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Tocilizumab Inferred relationship Existential restriction modifier 1
Administration of tocilizumab Direct substance True Tocilizumab Inferred relationship Existential restriction modifier 1
Adverse reaction to tocilizumab Causative agent True Tocilizumab Inferred relationship Existential restriction modifier 1
Tocilizumab 200mg/10ml solution for infusion vials Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 80mg/4ml solution for infusion vials Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 400mg/20ml solution for infusion vials Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 200mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 200mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 80mg/4ml solution for infusion vials 1 vial Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 80mg/4ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 400mg/20ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 400mg/20ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 200mg/10ml solution for infusion vials Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 80mg/4ml solution for infusion vials Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 200mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 80mg/4ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 400mg/20ml solution for infusion vials 1 vial Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 400mg/20ml solution for infusion vials Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled syringes (Roche Products Ltd) Has active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled syringes (Roche Products Ltd) Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes 4 pre-filled disposable injection Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled syringes (Roche Products Ltd) 4 pre-filled disposable injection Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices Has active ingredient False Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices 4 pre-filled disposable injection Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier
RoActemra 162mg/0.9ml solution for injection pre-filled pens (Roche Products Ltd) 4 pre-filled disposable injection Has specific active ingredient True Tocilizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start